[company_age]28.0[/company_age][employees]201-500 employees[/employees][funding]Seed[/funding][description]deCODE genetics is a global leader in human genetics, leveraging its unique expertise and population resources to analyze and understand the human genome. The company has discovered key genetic risk factors for dozens of common diseases, ranging from cardiovascular disease to cancer. deCODE's mission is to use this knowledge to develop new methods for diagnosing, treating, and preventing diseases. \n\ndeCODE operates the most productive human gene discovery engine in the world, employing its discoveries to identify genetic variations associated with human disease. The company's research has led to the development of several novel diagnostic and therapeutic tools, including a genetic test for Alzheimer's disease and a drug for the treatment of rheumatoid arthritis. \n\ndeCODE is a subsidiary of Amgen, a leading global biotechnology company. The company has a strong track record of innovation and collaboration, and it is committed to making its discoveries available to patients and healthcare providers worldwide.[/description][ps]Genetic analysis, disease risk assessment, drug discovery[/ps]